IFNG and cancer: A decreased IFN-γ level, associated with the rs1861494-G allele, could both deregulate the anti-proliferative activity of IFN-γ and alter the 5-FU cytotoxicity toward cancer cells (Figure 4), resulting in an increased risk of CRC recurrence and poor prognosis, as reported by the current paper.